Research Papers

25 of 284 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
GenIDA: an international participatory database to gain knowledge on health issues related to genetic forms of neurodev…
Burger P; Colin F; Strehle A; Mazzucotelli T; Collot N; Coutelle R; Durand B; Bouman A; Landau Prat D; Kleefstra T; Parrend P; Piton A; Koolen DA; Mandel JL.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Environmental opportunities facilitating cognitive development in preschoolers: development of a multicriteria index.
Nobre JNP; Morais RLS; Prat BV; Fernandes AC; Viegas ÂA; Figueiredo PHS; Peixoto MF; De Oliveira Ferreira F; de Freitas PM; Mendonça VA; Lacerda ACR.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries.
Bokobza C; Jacquens A; Guenoun D; Bianco B; Galland A; Pispisa M; Cruz A; Zinni M; Faivre V; Roumier A; Lebon S; Vitalis T; Csaba Z; Le Charpentier T; Schwendimann L; Young-Ten P; Degos V; Monteiro P; Dournaud P; Gressens P; Van Steenwinckel J.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The pathobiological basis of depression in Parkinson disease: challenges and outlooks.
Jellinger KA.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Corticobasal syndrome and Parkinson's disease at the beginning: asymmetrical patterns of MRI and Blink Reflex for early…
Donzuso G; Sciacca G; Luca A; Cicero CE; Mostile G; Nicoletti A; Zappia M.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Non-motor symptoms burden in motor-fluctuating patients with Parkinson's disease may be alleviated by safinamide: the V…
De Masi C; Liguori C; Spanetta M; Fernandes M; Cerroni R; Garasto E; Pierantozzi M; Mercuri NB; Stefani A.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatri…
Schulze Westhoff M; Groh A; Schröder S; Proskynitopoulos PJ; Jahn K; Klietz M; Krichevsky B; Stichtenoth DO; Wedegärtner F; Bleich S; Frieling H; Heck J.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Potency of botulinum toxin drugs: test systems and labelling.
Dressler D; Johnson EA.
J Neural Transm (Vienna) (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Changes in the TMS-evoked potential N100 in the dorsolateral prefrontal cortex as a function of depression severity in …
Biermann L; Wunram HL; Pokorny L; Breitinger E; Großheinrich N; Jarczok TA; Bender S.
J Neural Transm (Vienna) (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson's disease: post-hoc analysi…
Hattori N; Kamei T; Ishida T; Suzuki I; Nomoto M; Tsuboi Y.
J Neural Transm (Vienna) (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Glucocerebrosidase mutations and Parkinson disease.
Vieira SRL; Schapira AHV.
J Neural Transm (Vienna) (Unknown)
Published: 2022
1/6 Transparent
Treadmill training and physiotherapy similarly improve dual task gait performance: a randomized-controlled trial in Par…
Gaßner H; Trutt E; Seifferth S; Friedrich J; Zucker D; Salhani Z; Adler W; Winkler J; Jost WH.
J Neural Transm (Vienna) (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Essential tremor plus rest tremor: current concepts and controversies.
Erro R; Sorrentino C; Russo M; Barone P.
J Neural Transm (Vienna) (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Impact of the COVID-19 pandemic on mental health and family situation of clinically referred children and adolescents i…
Werling AM; Walitza S; Eliez S; Drechsler R.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Bioinformatics approach reveals the critical role of the NOD-like receptor signaling pathway in COVID-19-associated mul…
Qiu D; Zhang D; Yu Z; Jiang Y; Zhu D.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
GBA-associated PD: chances and obstacles for targeted treatment strategies.
Höglinger G; Schulte C; Jost WH; Storch A; Woitalla D; Krüger R; Falkenburger B; Brockmann K.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Diagnostic value of micrographia in Parkinson's disease: a study with [<sup>123</sup>I]FP-CIT SPECT.
Eklund M; Nuuttila S; Joutsa J; Jaakkola E; Mäkinen E; Honkanen EA; Lindholm K; Vahlberg T; Noponen T; Ihalainen T; Murtomäki K; Nojonen T; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Life style and Parkinson's disease.
Reichmann H; Csoti I; Koschel J; Lorenzl S; Schrader C; Winkler J; Wüllner U.
J Neural Transm (Vienna) (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in …
Falkenburger B; Kalliakoudas T; Reichmann H.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.
Lingor P; Demleitner AF; Wolff AW; Feneberg E.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.
Sirin S; Nigdelioglu Dolanbay S; Aslim B.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Distinct gait dimensions are modulated by physical activity in Parkinson's disease patients.
Bastos P; Meira B; Mendonça M; Barbosa R.
J Neural Transm (Vienna) (Unknown)
Published: 2022
5/6 Transparent
Data Code Funding Declared
Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine ("Ecstasy") i…
Bavato F; Stamatakos S; Ohki CMY; Seifritz E; Romualdi P; Grünblatt E; Quednow BB.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Botulinum toxin therapy: past, present and future developments.
Dressler D; Johnson EA.
J Neural Transm (Vienna) (Unknown)
Published: 2022
2/6 Transparent
Funding Declared
Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: …
Ruppert K; Geffert C; Clement HW; Bachmann C; Haberhausen M; Schulz E; Fleischhaker C; Biscaldi-Schäfer M.
J Neural Transm (Vienna) (Unknown)
Published: 2022
3/6 Transparent
Funding Declared